Personalized Magnetic Brain Stimulation to Improve Arm Use After Stroke
Tests tailored magnetic brain stimulation to aid arm recovery in people with recent stroke.
Plain-language title generated from the registry record
Registry title: Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients
Key facts
- Where
- Seoul, South KoreaSee the site
Where in South Korea
- Samsung Medical CenterSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Samsung Medical Center
- Trial code
- NCT06270238
- Record updated
- 24 April 2026
- Original description
The objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each hemiplegic stroke patient in subacute phase, compared to conventional low-frequency rTMS therapy on contralateral M1. Investigators hypothesized that the functional reserve of each hemiplegic stroke patient will be different, and therefore an appropriate simulating target for rTMS therapy is needed. In addition, this approach could be more effective compared to conventional protocols applied to stroke patients regardless of their severity, predicted mechanism of motor function recovery, or functional reserves.Read full original descriptionShow less
Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients: A Multi Center, Randomized, Single Blind, Parallel Group Prospective Clinical Trial
The objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each hemiplegic stroke patient in subacute phase, compared to conventional low-frequency rTMS therapy on contralateral M1. Investigators hypothesized that the functional reserve of each hemiplegic stroke patient will be different, and therefore an appropriate simulating target for rTMS therapy is needed. In addition, this approach could be more effective compared to conventional protocols applied to stroke patients regardless of their severity, predicted mechanism of motor function recovery, or functional reserves.
Inclusion: hemiplegic stroke patients in the subacute phase (7 days to 3 months from the onset) who are currently hospitalized,; FMA score of the upper extremity ≤42,; adequate language and cognitive function to perform at least a 1-step obey-command,; pre-stroke functional level of modified Rankin Scale (mRS) ≤1,; aged ≥19 years old,; patients willing to sign the informed consent.
Exclusion: those with contraindications to rTMS, such as epilepsy, implanted metal objects in the head, or a history of craniotomy,; those with progressive of hemodynamically unstable medical conditions,; those with coexisting neurological conditions, such as spinal cord injury or Parkinson's disease,; those with major psychiatric disorders, such as major depression, schizophrenia, or dementia,; those having contraindications to conduct an MRI study,; those who are pregnant or lactating ,; patients who have refused to participate in this study.